Adma Biologics (ADMA) Receivables - Net (2012 - 2026)
Adma Biologics' Receivables - Net came in at $138.23 million for Q2 2026, up 26.0% from $109.73 million a year earlier and up 1.7% from the prior quarter.
Powered by 
Analysis
Adma Biologics (ADMA) Receivables - Net (2012 - 2026) Analysis & Trends
At the end of FY2025, Adma Biologics' Receivables - Net was $158.43 million, up 216.9% from FY2024.
- Receivables - Net has increased in each of the last three years, with a five-year compound annual growth rate of 64.3% (FY2020 to FY2025).
- Going back by year, Receivables - Net was $50 million in FY2024 (+82.3%), $27.42 million in FY2023 (+76.9%), $15.51 million in FY2022 (-45.7%) and $28.58 million in FY2021 (+115.9%).
- The five-year range for quarterly Receivables - Net is $15.51 million (Q4 2022) to $158.43 million (Q4 2025).
- Year-over-year, Receivables - Net has increased for eight consecutive quarters, with growth averaging 120.2% over the last eight quarters.
- The fastest year-over-year change in Receivables - Net over five years came in Q2 2025 (growth of 264.4%), and the weakest in Q4 2022 (a decline of 45.7%).
- Business Quant data shows ADMA's Receivables - Net at $135.86 million (Q1 2026), $158.43 million (Q4 2025) and $137.67 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Adma Biologics | 2.28 Bn | 1.86 Bn | 86.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 138.23 Mn |
| Mar 31, 2026 | 135.86 Mn |
| Dec 31, 2025 | 158.43 Mn |
| Sep 30, 2025 | 137.67 Mn |
| Jun 30, 2025 | 109.73 Mn |
| Mar 31, 2025 | 99.41 Mn |
| Dec 31, 2024 | 50.00 Mn |
| Sep 30, 2024 | 50.14 Mn |
| Jun 30, 2024 | 30.11 Mn |
| Mar 31, 2024 | 49.62 Mn |
| Dec 31, 2023 | 27.42 Mn |
| Sep 30, 2023 | 31.32 Mn |
| Jun 30, 2023 | 36.73 Mn |
| Mar 31, 2023 | 26.52 Mn |
| Dec 31, 2022 | 15.51 Mn |
| Sep 30, 2022 | 20.90 Mn |
| Jun 30, 2022 | 18.88 Mn |
| Mar 31, 2022 | 25.63 Mn |
| Dec 31, 2021 | 28.58 Mn |
| Sep 30, 2021 | 20.39 Mn |
API Access
Adma Biologics Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=ADMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "ADMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=ADMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();